Financial News
Latest News about Briefs
Recent news which mentions Briefs
From Benzinga
Ozempic And Wegovy Linked to Increased Suicidal Thoughts In Observational Study, But Results Are Contested
August 20, 2024
From Benzinga
What's Going On With Nvidia Stock On Tuesday?
August 20, 2024
From Benzinga
MediaAlpha Positioned for Strong Growth in Expanding Insurance Digital Advertising Market, Says Goldman Sachs
August 20, 2024
From Benzinga
Lowe's Q2 Earnings: Analysts Highlight Margin Strength Despite Revenue Miss and Sales Pressure
August 20, 2024
From Benzinga
What's Going On With Realty Income Stock Tuesday?
August 20, 2024
From Benzinga
What's Going On With Wells Fargo Stock Tuesday?
August 20, 2024
From Benzinga
From Benzinga
ARS Pharmaceuticals 'Neffy Uniquely Positioned With Potential To Change Allergy Treatment Paradigm For First Time In 40 years:' Analyst
August 20, 2024
From Benzinga
Arbitration To Uncover Hidden Value Of Hess' Guyana Oil Assets In Exxon Mobil vs. Chevron Dispute: Report
August 20, 2024
From Benzinga
From Benzinga
What's Going On With Lucid Group Stock On Tuesday?
August 20, 2024
From Benzinga
What's Going On With AMD Stock Tuesday?
August 20, 2024
From Benzinga
From Benzinga
From Benzinga
From Benzinga
What's Going On With Trump Media & Tech Stock On Tuesday?
August 20, 2024
From Benzinga
InMed Pharmaceuticals Advances Oral Candidate For Alzheimer's Disease, Stock Surges On Tuesday
August 20, 2024
From Benzinga
Whistleblower Lawsuit Against Humana: Settles Medicare Part D Fraud Allegations For $90M
August 20, 2024
From Benzinga
Why Navios Maritime Partners Shares Are Surging Tuesday
August 20, 2024
From Benzinga
From Benzinga
From Benzinga
Why Is AI Audio Platform Auddia Stock Gaining Today?
August 20, 2024
From Benzinga
From Benzinga
NIO Sets The Stage For A Charging Revolution: Reportedly Plans Massive Expansion At Power Up 2024 Event
August 20, 2024
From Benzinga
Kroger Takes Legal Action Against FTC's Merger Review, Claims Proceeding As 'Unconstitutional'
August 20, 2024
From Benzinga
Eli Lilly's Famed Obesity/Diabetes Treatment Tirzepatide Shows Potential To Cut Risk Of Developing Diabetes, Sustained Weight Loss Over 3 Years
August 20, 2024
From Benzinga
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.